8-K: Butterfly Network Reports Record Q2 2026 Revenue, Beats Guidance

Butterfly Network announced record Q2 2026 revenue of $32.6 million, a 39% year-over-year increase, and improved adjusted EBITDA loss, exceeding guidance.

Summary

• Butterfly Network reported record second quarter 2026 revenue of $32.6 million, a 39% increase compared to $23.4 million in Q2 2025.
• Gross margin improved to 71.4% from 63.7% in the prior year period.
• Operating expenses increased by 19% to $37.0 million, driven by investments in headcount to support revenue growth and product development.
• Net loss for the quarter was $12.9 million, an improvement from $13.8 million in Q2 2025.
• Adjusted EBITDA loss was $1.4 million, a significant improvement from $6.2 million in the prior year period.
• The company raised its full-year 2026 revenue guidance to $119 million $123 million and improved its adjusted EBITDA guidance.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, with record revenue, improved margins, and raised guidance indicating robust business momentum and successful execution of strategic initiatives.

Positives

• Record quarterly revenue of $32.6 million, up 39% year-over-year.
• Gross margin increased to 71.4% from 63.7% in Q2 2025.
• Adjusted EBITDA loss improved significantly to $1.4 million from $6.2 million in Q2 2025.
• Raised full-year 2026 revenue guidance to $119 million $123 million.
• Improved full-year 2026 adjusted EBITDA guidance.
• Added two new partners to the Butterfly Embedded portfolio, totaling 11.
• Received provisional authorization to sell across the U.S. Department of Veterans Affairs.
• Received regulatory authorization in Brazil.

Negatives

• Operating expenses increased by 19% to $37.0 million.
• International revenue decreased by 14% year-over-year to $5.0 million.
• Net loss for the quarter was $12.9 million.

Risks

• The company faces significant known and unknown risks and uncertainties that could cause actual results to differ materially from forward-looking statements.
• Factors include the ability to grow and manage growth effectively, the success and timing of product development, market acceptance of products, obtaining and maintaining regulatory approvals, and competition from companies with greater financial resources.
• Global macroeconomic conditions, including tariffs, geopolitical conflicts, and AI-driven supply chain shortages, could impact business and operations.
• The company's ability to protect or enforce its intellectual property rights is a risk.

Future Outlook

The company raised its full-year 2026 revenue guidance to $119 million to $123 million (22%-26% growth) and improved its adjusted EBITDA loss guidance to $19 million to $23 million. For Q3 2026, revenue is projected between $26 million to $30 million (approximately 30% growth) with an adjusted EBITDA loss of $6 million to $9 million.

Management Comments

• "Butterfly delivered another outstanding quarter, exceeding the high end of our guidance while achieving record revenue, gross margin and adjusted EBITDA."
• "Just as important, the world got to see what Ultrasound-on-Chip is capable of as two Embedded partners unveiled entirely new applications being built on our platform."
• "Butterfly has evolved into a multi-engine growth company. Our semiconductor platform is expanding into new markets through Butterfly Embedded; our POCUS business is building a larger enterprise opportunity through software, medical education and government; and Home & Community Care is transitioning from pilot to commercialization."

Industry Context

StockSavvy.ai notes that Butterfly Network's strong revenue growth and improved margins in Q2 2026 reflect a positive trend in the adoption of its innovative ultrasound technology, particularly within its Embedded and POCUS segments. The company's strategic expansion into new markets and applications, alongside its progress in regulatory approvals like FedRAMP, positions it to capitalize on the growing demand for accessible and advanced medical imaging solutions.

Comparison to Industry Standards

• The 39% year-over-year revenue growth for Butterfly Network in Q2 2026 significantly outpaces the typical growth rates seen in the broader medical device industry, which often experiences single to low double-digit growth.
• The improvement in gross margin to 71.4% is a strong indicator of operational efficiency and the increasing contribution of higher-margin software and licensing revenue, a trend that many hardware-centric medical technology companies strive for.
• While still reporting an adjusted EBITDA loss, the substantial reduction (78%) indicates a positive trajectory towards profitability, which is a key focus for investors in growth-stage technology companies within the healthcare sector.

Stakeholder Impact

• Shareholders: Positive impact due to record revenue, improved financial metrics, and raised guidance, suggesting potential for increased shareholder value.
• Customers: Continued innovation and expansion of product offerings, including new applications and international market access, benefit customers.
• Partners: Growth in the Butterfly Embedded program and Butterfly Garden ecosystem indicates expanding opportunities for partners.

Next Steps

• Achieve FedRAMP certification in the third quarter of 2026.
• Prepare for first commercial implementation of Home & Community Care in the second half of 2026.
• Expect revenue from Home & Community Care in the fourth quarter of 2026.
• Expect three existing partner tools on Butterfly Garden to become commercially available by year-end.

Key Dates

Recommendation

The company demonstrated exceptional Q2 performance with record revenue, significant gross margin expansion, and a substantial improvement in adjusted EBITDA loss, all while exceeding guidance. The raised full-year outlook and strategic expansion into new markets via Butterfly Embedded and other initiatives highlight strong execution and a compelling growth trajectory. These factors collectively suggest a highly favorable outlook for the company's stock.

Keywords

Ultrasound-on-Chip, Butterfly Embedded, POCUS, Medical Imaging, Semiconductor, AI, Healthcare Technology, Revenue Growth